Trial intelligence / Profile preview

Serial Lidocaine Infusion for Peripheral Neuropathic Pain

NCT02217267Phase 3Completed

Sponsor
Mahidol University
Start
Aug 2014
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in Peripheral neuropathic pain, sponsored by Mahidol University. Started Aug 2014; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

Peripheral neuropathic pain

Beyond the preview

Go deeper on NCT02217267.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02217267.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call